CTOs on the Move

Advantia Health

www.advantiahealth.com

 
Advantia is transforming healthcare for all women - we`re setting a higher standard of care and convenience while reducing unnecessary costs. Compassion and value inspire everything we do. We take time to listen, answer questions completely, and offer helpful technology between visits so that our patients are empowered and at ease. Alongside coordinated care, Advantia is pioneering care models that align incentives with the best interests of women and their families.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Advantia Health raised $45M on 01/08/2020

Similar Companies

Nationwide Wheelchair

Nationwide Wheelchair is a Melbourne, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Millcreek Behavioral Health

Millcreek Behavioral Health is a residential treatment center in Arkansas for children and adolescents struggling with depression, addiction, bipolar, aggression, and sexual reactive behaviors.

Northern Michigan Regional Hospital

Northern Michigan Regional Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Northern Michigan Regional Hospital is based in Petoskey, MI. You can find more information on Northern Michigan Regional Hospital at www.northernhealth.org

TrueVision Systems

TrueVision Systems is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForSight VISION5

ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.